Literature DB >> 19756501

Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children.

Mojca Groselj-Grenc1, Alojz Ihan, Maja Pavcnik-Arnol, Andreja Natasa Kopitar, Tanja Gmeiner-Stopar, Metka Derganc.   

Abstract

OBJECTIVE: To compare the diagnostic accuracy of neutrophil and monocyte CD64 indexes (CD64in and CD64im) for sepsis in critically ill neonates and children with that of lipopolysaccharide-binding protein (LBP), procalcitonin (PCT) and C-reactive protein (CRP). DESIGN AND
SETTING: Prospective, observational study in a level III multidisciplinary neonatal and pediatric intensive care unit (ICU). PATIENTS: Forty-six neonates and 36 children with systemic inflammatory response syndrome (SIRS) and suspected infection, classified into two groups: those with bacterial sepsis (microbiologically proven or clinical sepsis) and those without bacterial sepsis (infection not supported by subsequent clinical course, laboratory data and microbiological tests). INTERVENTIONS AND MEASUREMENTS: Flow cytometric CD64in and CD64im, serum LBP, PCT and CRP measurement on 2 consecutive days from admission to the ICU.
RESULTS: There were 17 cases of bacterial sepsis in neonates and 24 cases of bacterial sepsis in children. All neonates and the majority of children were mechanically ventilated, and more than two-thirds of neonates with sepsis and one-third of children with sepsis needed inotropic/vasopressor drugs. The highest diagnostic accuracy for sepsis on the 1st day of suspected sepsis was achieved by LBP in neonates (0.86) and by CD64in in children (0.88) and 24 h later by CD64in in neonates (0.96) and children (0.98).
CONCLUSIONS: Neutrophil CD64 index (CD64in) is the best individual marker for bacterial sepsis in children, while in neonates the highest diagnostic accuracy at the time of suspected sepsis was achieved by LBP and 24 h later by CD64in.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756501     DOI: 10.1007/s00134-009-1637-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  41 in total

1.  Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS).

Authors:  S S Qureshi; S M Lewis; V A Gant; D Treacher; B H Davis; K A Brown
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  Quantitative measurement of monocyte HLA-DR expression in the identification of early-onset neonatal infection.

Authors:  Pak Cheung Ng; Geng Li; Kit Man Chui; Winnie Chiu Wing Chu; Karen Li; Raymond Pui On Wong; Tai Fai Fok
Journal:  Biol Neonate       Date:  2005-09-12

3.  [Expression of peripheral blood neutrophil CD64 in neonatal septicemia].

Authors:  Jie Shao; Xin-wen Huang; Mei-yue Sun; Li-zhong DU; Yong-min Tang; Yuan-luo Le
Journal:  Zhonghua Er Ke Za Zhi       Date:  2005-07

4.  Expression of CD64 as a potential marker of neonatal sepsis.

Authors:  Esther Layseca-Espinosa; Luis F Pérez-González; Abraham Torres-Montes; Lourdes Baranda; Hortensia de la Fuente; Yvonne Rosenstein; Roberto González-Amaro
Journal:  Pediatr Allergy Immunol       Date:  2002-10       Impact factor: 6.377

5.  Lipopolysaccharide-binding protein in noninfected neonates and those with suspected early-onset bacterial infection.

Authors:  T W Orlikowsky; C Trüg; F Neunhoeffer; M Deperschmidt; M Eichner; C F Poets
Journal:  J Perinatol       Date:  2006-02       Impact factor: 2.521

Review 6.  Definitions of bloodstream infection in the newborn.

Authors:  Khalid N Haque
Journal:  Pediatr Crit Care Med       Date:  2005-05       Impact factor: 3.624

7.  Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children.

Authors:  A Enguix; C Rey; A Concha; A Medina; D Coto; M A Diéguez
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

8.  Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.

Authors:  Juan Casado-Flores; Alfredo Blanco-Quirós; Julia Asensio; Eduardo Arranz; Jose A Garrote; Monserrat Nieto
Journal:  Pediatr Crit Care Med       Date:  2003-04       Impact factor: 3.624

9.  Virus diseases in ICU patients: a long time underestimated; but be aware of overestimation.

Authors:  Charles-Edouard Luyt
Journal:  Intensive Care Med       Date:  2006-05-24       Impact factor: 17.440

10.  Early expression of FcgammaRI (CD64) on monocytes of cardiac surgical patients and higher density of monocyte anti-inflammatory scavenger CD163 receptor in "on-pump" patients.

Authors:  Martina Kolackova; Manuela Kudlova; Pavel Kunes; Vladimir Lonsky; Jiri Mandak; Ctirad Andrys; Karolina Jankovicova; Jan Krejsek
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

View more
  36 in total

1.  Hematologic profile of the fetus with systemic inflammatory response syndrome.

Authors:  Roberto Romero; Zeynep Alpay Savasan; Tinnakorn Chaiworapongsa; Stanley M Berry; Juan Pedro Kusanovic; Sonia S Hassan; Bo Hyun Yoon; Samuel Edwin; Moshe Mazor
Journal:  J Perinat Med       Date:  2011-09-30       Impact factor: 1.901

2.  The sensitivity of neutrophil CD64 expression as a biomarker of bacterial infection is low in critically ill patients.

Authors:  Antoine Gros; Mikael Roussel; Elise Sauvadet; Arnaud Gacouin; Sophie Marqué; Loïc Chimot; Sylvain Lavoué; Christophe Camus; Thierry Fest; Yves Le Tulzo
Journal:  Intensive Care Med       Date:  2012-02-04       Impact factor: 17.440

3.  Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.

Authors:  Lidija Kitanovski; Janez Jazbec; Sergej Hojker; Metka Derganc
Journal:  Support Care Cancer       Date:  2013-09-21       Impact factor: 3.603

Review 4.  Biomarkers for pediatric sepsis and septic shock.

Authors:  Stephen W Standage; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2011-01       Impact factor: 5.091

5.  Severe pneumonia due to infection with Candida krusei in a case of suspected Middle East respiratory syndrome: A case report and literature review.

Authors:  Mingming Tan; Junwei Wang; Peiyang Hu; Bin Wang; Wanghua Xu; Jiao Chen
Journal:  Exp Ther Med       Date:  2016-11-11       Impact factor: 2.447

6.  Neutrophil CD64 expression is a predictor of mortality for patients in the intensive care unit.

Authors:  Qiqi Chen; Junfeng Shi; Aihua Fei; Feilong Wang; Shuming Pan; Weiwei Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

7.  Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology.

Authors:  Marc Augsburger; Katia Iglesias; Daniel Bardy; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-10-13       Impact factor: 2.686

Review 8.  Year in review in Intensive Care Medicine 2009. Part III: mechanical ventilation, acute lung injury and respiratory distress syndrome, pediatrics, ethics, and miscellanea.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-02-23       Impact factor: 17.440

9.  Timing and predictors of fever and infection after craniotomy for epilepsy in children.

Authors:  Jennifer Phung; Gary W Mathern; Paul Krogstad
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

10.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.